 |
PDBsum entry 4a9c
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Crystal structure of human ship2 in complex with biphenyl 2,3',4,5',6- pentakisphosphate
|
|
Structure:
|
 |
Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 2. Chain: a, b. Fragment: phosphatase domain, residues 419-732. Synonym: inositol polyphosphate phosphatase-like protein 1, inppl-1, protein 51c, sh2 domain-containing inositol-5'-phosphatase 2, sh2 domain-containing inositol phosphatase 2, ship-2. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 469008. Expression_system_variant: r3 prare.
|
|
Resolution:
|
 |
|
2.10Å
|
R-factor:
|
0.202
|
R-free:
|
0.221
|
|
|
Authors:
|
 |
L.Tresaugues,C.H.Arrowsmith,H.Berglund,C.Bountra,A.M.Edwards, T.Ekblad,S.Graslund,T.Karlberg,S.J.Mills,M.Moche,T.Nyman,C.Persson, B.V.L.Potter,H.Schuler,A.G.Thorsell,J.Weigelt,P.Nordlund
|
|
Key ref:
|
 |
S.J.Mills
et al.
(2012).
A synthetic polyphosphoinositide headgroup surrogate in complex with SHIP2 provides a rationale for drug discovery.
Acs Chem Biol,
7,
822-828.
PubMed id:
|
 |
|
Date:
|
 |
|
25-Nov-11
|
Release date:
|
30-May-12
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B:
E.C.3.1.3.86
- phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate) + H2O = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4- bisphosphate) + phosphate
|
 |
 |
 |
 |
 |
1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate)
|
+
|
H2O
|
=
|
1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4- bisphosphate)
|
+
|
phosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Acs Chem Biol
7:822-828
(2012)
|
|
PubMed id:
|
|
|
|
|
| |
|
A synthetic polyphosphoinositide headgroup surrogate in complex with SHIP2 provides a rationale for drug discovery.
|
|
S.J.Mills,
C.Persson,
G.Cozier,
M.P.Thomas,
L.Trésaugues,
C.Erneux,
A.M.Riley,
P.Nordlund,
B.V.Potter.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|